Synthesis and use of .alpha.-ketoamide derivatives and arrays
AssigneeArQule, Inc.
InventorsCarmen M. Baldino, David L. Coffen, Stewart D. Chipman, Hong Cheng
Life of this patent
Estimating the term…
Loading patent…
AssigneeArQule, Inc.
InventorsCarmen M. Baldino, David L. Coffen, Stewart D. Chipman, Hong Cheng
Estimating the term…
The invention is based on new methods for making and using compounds and arrays of novel .alpha.-ketoamides, and the arrays and compounds made by these methods. These novel compounds are potential inhibitors of proteolytic enzymes, particularly cysteine proteases such as cruzain. Application of the new methods has led to the identification of a number of new inhibitors, from amongst an array of about 38,000 .alpha.-ketoamide derivatives, having specific activity against three cysteine proteases: cruzain, papain, and cathepsin B. These compounds and other compounds identified by the methods described herein can be useful, for example, in developing pharmaceutic agents for the treatment of diseases (e.g., Chagas' disease) associated with these proteases. Although the disclosed compounds have specific activity for cruzain, papain, cathepsin B, the methods described herein can also be used to identify inhibitors of other proteases.
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
A non-peptidyl compound represented by the formula:
The compound of claim 15, wherein the compound is an inhibitor of a cysteine protease.
Dependencies are inferred from the claim text.